Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes
eLife · 2023
DOI: 10.7554/elife.79144 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Eli Olson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Michigan Medicine, University of Michigan-Ann Arbor, Ann Arbor, United States. Hauptthemen laut MEDLINE: Antigen Presentation, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
The extreme polymorphisms of human leukocyte antigen class I (HLA class I) proteins enable the presentation of diverse peptides to cytotoxic T lymphocytes. The canonical endoplasmic reticulum (ER) HLA class I assembly pathway enables presentation of cytosolic peptides, but effective intracellular surveillance requires multi-compartmental antigen sampling. Endo-lysosomes are generally sites of HLA class II assembly, but human monocytes and monocyte-derived dendritic cells (moDCs) also contain significant reserves of endo-lysosomal HLA class I molecules. We hypothesized variable influences of HLA class I polymorphisms upon outcomes of endo-lysosomal trafficking, as the stabilities and peptide occupancies of cell surface HLA class I molecules are variable. Consistent with this model, when the endo-lysosomal pH of moDCs is disrupted, HLA-B allotypes display varying propensities for reductions in surface expression, with HLA-B*08:01 or HLA-B*35:01 being among the most resistant or sensitive, respectively, among eight tested HLA-B allotypes. Perturbations of moDC endo-lysosomal pH result in accumulation of HLA-B*35:01 in LAMP1 + compartments and increase HLA-B*35:01 peptide receptivity. These findings reveal the intersection of the vacuolar cross-presentation pathway with a constitutive assembly pathway for some HLA-B allotypes. Notably, cross-presentation of epitopes derived from two soluble antigens was also more efficient for B*35:01 compared to B*08:01, even when matched for T cell response sensitivity, and more affected by cathepsin inhibition. Thus, HLA class I polymorphisms dictate the degree of endo-lysosomal assembly, which can supplement ER assembly for constitutive HLA class I expression and increase the efficiency of cross-presentation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Michigan Medicine, University of Michigan-Ann Arbor, Ann Arbor, United States.
- Graduate Program in Immunology, Michigan Medicine, University of Michigan-Ann Arbor, Ann Arbor, United States.
ORCID-Profile: Eli Olson, Theadora Ceccarelli, Malini Raghavan
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute of General Medical Sciences
- Herman and Dorothy Miller Fund
Zitieren
APA
Olson, E., Ceccarelli, T., & Raghavan, M. (2023). Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes. eLife. https://doi.org/10.7554/elife.79144
Vancouver
Olson E, Ceccarelli T, Raghavan M. Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes. eLife. 2023. doi:10.7554/elife.79144
BibTeX
@article{Olson2023,
author = {Olson, Eli and Ceccarelli, Theadora and Raghavan, Malini},
title = {Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.79144}
}
EUVIMED